Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia

Nicolas Duployez, Christophe Willekens, Isabelle Plo, Alice Marceau-Renaut, Stéphane de Botton, Laurène Fenwarth, Thomas Boyer, Guillemette Huet, Olivier Nibourel, Christian Rose, Brigitte Nelken, Bruno Quesnel, Claude Preudhomme

Blood (2019) 134 (26): 2414–2416.

https://doi.org/10.1182/blood.2019003206

Published: 2019

Includes: Supplemental data

Journal Articles

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Theodore Braun, MD PhD, Cody Coblentz, Sarah A Carratt, PhD BS, Mariam Okhovat, PhD, Amy Foley, MEng., Zachary Schonrock, BS, Kimberly Nevonen, Rhonda E. Ries, MA, Shannon K. McWeeney, PhD, Claus Nerlov, PhD, Soheil Meshinchi, MD PhD, Lucia Carbone, PhD, Brian J. Druker, Julia E. Maxson, PhD

Blood (2019) 134 (Supplement_1): 543.

https://doi.org/10.1182/blood-2019-124773

Published: 2019

Journal Articles

Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms

Pinkal Desai, MDMPH, Niamh Savage, BA, Spencer Krichevsky, BS, Tania Curcio, Sangmin Lee, MD, Michael B. Samuel, MD, Ellen K. Ritchie, MD, Gail J. Roboz, MD

Blood (2019) 134 (Supplement_1): 1666.

https://doi.org/10.1182/blood-2019-127663

Published: 2019

Journal Articles

New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies

Amy M Trottier, MDBSc,MSc, Ira L Kraft, MD, Lawrence J Druhan, PhD, Amanda Lance, MS, Belinda R Avalos, MD, Lucy A Godley, MD PhD

Blood (2019) 134 (Supplement_1): 2543.

https://doi.org/10.1182/blood-2019-129492

Published: 2019

Journal Articles

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Blood (2019) 134 (11): 867–879.

https://doi.org/10.1182/blood.2019000611

Published: 2019

Includes: Supplemental data

Journal Articles

Neutrophilic leukemoid reaction associated with plasma cell neoplasm mimicking chronic neutrophilic leukemia

Wei Xie, Jie Xu

Blood (2019) 133 (2): 182.

https://doi.org/10.1182/blood-2018-10-881532

Published: 2019

Journal Articles

FOS Expression Distinguishes Two Groups of Atypical CML (aCML) Allowing Targeted Therapy

Manja Meggendorfer, PhD, Wencke Walter, PhD, Stephan Hutter, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2018) 132 (Supplement 1): 3893.

https://doi.org/10.1182/blood-2018-99-111832

Published: 2018

Journal Articles

Loss of DUSP1 Is Synthetic Lethal to JAK2 V617F

Meenu Kesarwani, Zachary Kincaid, BS, Tahir Latif, MD, Mohammad Azam, PhD

Blood (2018) 132 (Supplement 1): 51.

https://doi.org/10.1182/blood-2018-99-115503

Published: 2018

Journal Articles

DUSP1 Confers Oncogene Dependence in CSF3R Induced Leukemia

Meenu Kesarwani, Zachary Kincaid, BS, Mohammad Azam, PhD

Blood (2018) 132 (Supplement 1): 1341.

https://doi.org/10.1182/blood-2018-99-119092

Published: 2018

Journal Articles

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Vasily Shuvaev, MD, Karina Krutikova, MD, Svetlana Menshakova, MD, Natalya Kalinova, MD, Irina Martynkevich, MD PhD, Lyubov Polushkina, MD, Elena Belyakova, MD, Yury Krivolapov, MD PhD, Sergei Voloshin, MD PhD

Blood (2018) 132 (Supplement 1): 5483.

https://doi.org/10.1182/blood-2018-99-114885

Published: 2018

Journal Articles

Genotypic Representation of Myelodysplastic/Myeloproliferative Neoplasms in Nrg, Nrg-3GS and Srg-W41 Mice with Transgenic Expression of Human Cytokines

Hein Than, MD FRCPath, MRCP, Naoto Nakamichi, MD PhD, Anthony D. Pomicter, MS, John O'Shea, PhD, Orlando Antelope, Thomas O'Hare, PhD, Connie J. Eaves, PhD, Michael W. Deininger, MD PhD

Blood (2018) 132 (Supplement 1): 2038.

https://doi.org/10.1182/blood-2018-99-111728

Published: 2018

Journal Articles

Checkpoint Inhibition in CSF3R Mutated Chronic Neutrophilic Leukemia

Stefanie Kreutmair, MD, Teresa Poggio, Chuanjiang Yu, Sivahari Prasad Gorantla, Khalid Shoumariyeh, Dietmar Pfeifer, Michael Lubbert, MD PhD, Karsten Spiekermann, MD, Robert Zeiser, MD, Justus Duyster, Prof., Anna Lena Illert, MD

Blood (2018) 132 (Supplement 1): 3056.

https://doi.org/10.1182/blood-2018-99-113847

Published: 2018

Journal Articles

Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia

Theodore Braun, MD PhD, Amy Foley, MEng., Brian J. Druker, MD, Julia E. Maxson

Blood (2018) 132 (Supplement 1): 3067.

https://doi.org/10.1182/blood-2018-99-119213

Published: 2018

Journal Articles

Phase 2 Study of Ruxolitinib in Patients with Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Kim-Hien Dao, DO,PhD, Robert H. Collins, MD, Jorge E. Cortes, MD, Michael W. Deininger, MD PhD, Brian J. Druker, MD, Jason R. Gotlib, MDMS, Tara Alyson Macey, PhD, Stephen T Oh, MD PhD, Jeffrey W. Tyner, PhD, Elliott F. Winton, MD

Blood (2018) 132 (Supplement 1): 350.

https://doi.org/10.1182/blood-2018-99-119476

Published: 2018

Journal Articles

Fusion Transcripts without Corresponding Cytogenetic Abnormalities in Acute Myeloid Leukemia: Implications for AML Pathogenesis

Irene J. Locher, Wibowo Arindrarto, M.Sc., Daniel M. Borràs, M.Sc., M. Willy Honders, ing., Rick H. de Leeuw, ing., Wilma G.M. Kroes, PhD, Peter de Knijff, PhD, Cornelis A.M. van Bergen, PhD, Peter A.C. 't Hoen, PhD, Szymon M. Kielbasa, PhD, Jeroen F.J. Laros, PhD, Marieke Griffioen, PhD, Hendrik Veelken, MD PhD

Blood (2017) 130 (Supplement 1): 2703.

https://doi.org/10.1182/blood.V130.Suppl_1.2703.2703

Published: 2017

Journal Articles

Analysis of Patterns of Co-Occurrence and Mutual Exclusivity of Gene Mutations in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Fabio P S Santos, MD, Raquel MA Paiva, PhD, Renato D Puga, MSc, Giulliana AR Goncalves, MSc, Tarcila Santos Datoguia, MD, Welbert Oliveira, PhD, Bianca Lisboa, PhD, Ricardo Helman, MD PhD, Iracema Esteves, MD, Breno Gusmao, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MD PhD

Blood (2017) 130 (Supplement 1): 2934.

https://doi.org/10.1182/blood.V130.Suppl_1.2934.2934

Published: 2017

Journal Articles

Aberrant Trafficking and Signal Propagation By the T618I CSF3R Mutant in Patients with Chronic Neutrophilic Leukemia

Lawrence J Druhan, PhD, Andrea Price, Amanda Lance, Alicia Hamilton, Judy Parsons, MT, Fei Guo, PhD, David M Foureau, PhD, Nury M Steuerwald, PhD, Belinda Rene Avalos, MD

Blood (2017) 130 (Supplement 1): 2941.

https://doi.org/10.1182/blood.V130.Suppl_1.2941.2941

Published: 2017

Journal Articles

CSF3R Mutations Synergize with CEBPA and SETBP1 Mutations in Acute Myeloid Leukemia and Chronic Neutrophilic Leukemia

Amy Foley, MEng., Seamus B Hughes, Soheil Meshinchi, MD PhD, Julia E. Maxson, PhD

Blood (2017) 130 (Supplement 1): 3963.

https://doi.org/10.1182/blood.V130.Suppl_1.3963.3963

Published: 2017

Journal Articles

Coexisting Oncogenic Signaling Pathway Mutations in Cnl/Acml/CMML/MPN-U

Haijiao Zhang, Daniel Bottomly, Libbey K. White, Beth Wilmot, PhD, Shannon Mcweeney, PhD, Jeffrey W. Tyner, PhD

Blood (2017) 130 (Supplement 1): 4213.

https://doi.org/10.1182/blood.V130.Suppl_1.4213.4213

Published: 2017

Journal Articles

Genomics of chronic neutrophilic leukemia

Julia E. Maxson, Jeffrey W. Tyner

Blood (2017) 129 (6): 715–722.

https://doi.org/10.1182/blood-2016-10-695981

Published: 2017

NARROW

Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia

Myeloid-Lineage Enhancers Drive Oncogene Synergy and Represent a Novel Therapeutic Target in CSF3R-CEBPA Mutant AML

Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms

New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies

Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Neutrophilic leukemoid reaction associated with plasma cell neoplasm mimicking chronic neutrophilic leukemia

FOS Expression Distinguishes Two Groups of Atypical CML (aCML) Allowing Targeted Therapy

Loss of DUSP1 Is Synthetic Lethal to JAK2 V617F

DUSP1 Confers Oncogene Dependence in CSF3R Induced Leukemia

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Genotypic Representation of Myelodysplastic/Myeloproliferative Neoplasms in Nrg, Nrg-3GS and Srg-W41 Mice with Transgenic Expression of Human Cytokines

Checkpoint Inhibition in CSF3R Mutated Chronic Neutrophilic Leukemia

Function of ASXL1 Mutations in Chronic Neutrophilic Leukemia

Phase 2 Study of Ruxolitinib in Patients with Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

Fusion Transcripts without Corresponding Cytogenetic Abnormalities in Acute Myeloid Leukemia: Implications for AML Pathogenesis

Analysis of Patterns of Co-Occurrence and Mutual Exclusivity of Gene Mutations in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Aberrant Trafficking and Signal Propagation By the T618I CSF3R Mutant in Patients with Chronic Neutrophilic Leukemia

CSF3R Mutations Synergize with CEBPA and SETBP1 Mutations in Acute Myeloid Leukemia and Chronic Neutrophilic Leukemia

Coexisting Oncogenic Signaling Pathway Mutations in Cnl/Acml/CMML/MPN-U

Genomics of chronic neutrophilic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only